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Abstract: This article describes the updated GSI radiotherapy research facility (Cave M) located
at the GSI Helmholtz Center for Heavy Ion Research in Darmstadt, Germany. This facility was
upgraded by modernizing the beamline that supported a pilot project in carbon ion cancer therapy
in Europe from 1997 to 2008. Descriptions are provided of the modernized beamline, related
hardware components and treatment delivery system. The performance specifications and general
characteristics for each major component are described, along with example pre-clinical test results
of selected components. These upgrades to Cave M allow for investigating novel therapy methods.
The radiotherapy research facility is located on a beamline of the heavy ion synchrotron
(Schwer-Ionen-Synchrotron, or SIS-18) accelerator complex, capable of delivering 0.1 to 2 GeV/u
charged particle beams, ranging from protons to uranium. This beamline contains components for
fast beam gating, aborting, focusing, scanning, monitoring, and shifting the range of the beam. The
beam scanning magnets, position detectors, and beam monitors are described, along with tests of
functionality and performance. A dose delivery system (DDS) was adapted from a clinical unit at
the National Centre for Oncological Hadrontherapy (CNAO), Pavia, Italy, and consists of modular
real-time hardware and software. The DDS was modified to enable research on adaptively-managed
patient motion through the use of libraries of 4D-optimized radiation treatment plans, an unsolved
problem of importance for treating moving tumors. The system is modular and is designed to
support future research studies, such as high dose rate (Flash) radiotherapy and radioactive ion
beams.
A series of validation tests confirmed the functionality and performance of various key components and systems. For example, an end-to-end test revealed that dosimetric spatial homogeneity of
over 95% was achieved for square treatment fields. More generally, all performance characteristics
that were tested satisfied anticipated clinical requirements.
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Introduction

External-beam radiation therapy is a safe and non-invasive treatment for a wide variety of malignant diseases. The objective is to sterilize the tumor while sparing surrounding healthy tissue.
Most treatments utilize photon beams, yet beams of protons and heavier charged particles are of
increasing interest to treat radiation resistant tumors and in sites where radiation damage to healthy
tissues is of concern [1]–[3]. Synchrotrons and cyclotrons produce narrow ion beams that are
magnetically scanned laterally and modulated in penetration range to deliver highly conformal dose
distributions [4, 5]. Research with ion beams for therapy includes advanced technologies, such as
Flash [6], radioactive ion beams (RIB) [7], mixed species of ion beams [8], and advanced motion
mitigation strategies [9, 10]. Most research on these technologies have higher technical demands
than those of conventional ion therapy treatments, and, in some cases, go beyond the capabilities
of current medical accelerators. Therefore, research on these topics is commonly conducted at
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1

2

Methods and materials

In the following sections, we describe the layout, general specifications, and performance of beamline components in Cave M. The accelerator and beamlines are briefly reviewed here for the
convenience of the reader. This includes relevant upgrades to the synchrotron, beamline components (such as the beam line detectors, power supplies for scanning magnets, interfaces to the timing
system, beam request and scanning magnets, and the gating system) and the hardware and software of the dose delivery system (DDS). Additionally, we report selected preliminary performance
characteristics of the beam delivery system for radiotherapy research.

–2–

2021 JINST 16 T03004

dedicated accelerator research laboratories that can provide dedicated beamtime for experiments,
specialized technical support teams, and the possibility to modify beamlines and safety systems.
Typically, this type of research is more difficult, or even impossible, to conduct at a clinical facility
that is mainly utilized to treat patients. Currently, the pace of progress of research is constrained by
the scarcity of accelerator research facilities, as well as limitations in their capabilities and capacities
to support certain research activities.
Currently, there are 92 proton therapy centers and 14 heavy ion therapy centers worldwide [11],
with only a few capable of supporting research that relies on the delivery of beams with characteristics that are radically different from those currently used in clinical practice. Thus, beams
with potentially paradigm-shifting characteristics are scarce, which constitutes a gap in the needed
research infrastructure. For these reasons, as well as the difficulty of translating new treatment
paradigms to clinical practice, it is imperative to have research facilities that support research, development, and clinical translation efficiently. Ideally, such facilities can mimic the characteristics
of current clinical treatment systems [12], but also offers enhanced characteristics, additional capabilities for experimentation, and allows for rapid system modifications. In practice, several facilities
approach this ideal [13]–[17]. One of these, the radiotherapy research facility at GSI (frequently
denoted as Cave M), is the focus of this report. Construction of a predecessor therapy beamline was
completed in 1996 [18]. In 2008, after the successful technology transfer and commercialization
of the GSI therapy systems, patient treatments at GSI ceased and were resumed at a replacement
facility in Heidelberg [17]. Currently, GSI is modernizing and upgrading several of its research
facilities within the Facility for Antiproton and Ion Research (FAIR) [19, 20] project. This includes
significant upgrades of the SIS-18 synchrotron, including increased beam intensity, faster ramping
and improved beam extraction. The modernization of Cave M [4, 21], which began in 2016 and is
ongoing, is reported for the first time in this manuscript. The facility opened in 2020 for users within
the Biophysics Programme Advisory Committee (BioPAC) and the European Space Agency (ESA).
The objective of this work is to describe the general design, features, and selected preliminary
performance characteristics of the modernized Cave M. This includes beam monitoring and delivery
systems, peripheral components of the beam delivery system, and corresponding software to facilitate research, testing, and translation of new devices and technologies. We provide readers with an
update on the performance specifications and general characteristics of the beamline, as Cave M is
now available for users. The performance of the treatment control system (TCS) components was
characterized through beamline component tests and end-to-end tests.

2.1

SIS-18 accelerator and beamlines

Ions entering Cave M are accelerated in the synchrotron (figure 1). The SIS-18 can accelerate
ions ranging from hydrogen to uranium, with energies from 0.1 to 2 GeV/u for light ions and up to
4.7 GeV/u for protons [22]. It alternates between accelerating and spilling the beam, where each
spill is the extraction phase for one bunch of accelerated ions. During the GSI pilot project, carbon
beams of up to 2 × 108 ions per spill were available and slow extraction was utilized to deliver
beams with 2.2 s spill durations and 2.2 s pauses between spills. In addition to the slow extraction
method [13], fast resonance extraction is also available, which allows for delivering high intensity
particle beams, accumulated in several beam bunches, in a single burst, usually on the order of 1 μs
spill length [23]. The beamline was previously commissioned during the pilot project to deliver 80
to 430 MeV/u carbon ions to clinical safety standards [13].
As part of FAIR Phase-0, the synchrotron has undergone several modifications. Spill pauses
have been decreased to <1 s, and spill duration can vary between 0.5 s and more than 10 s, with full
cycle times of up to 20 s. Beam intensities of up to 1011 ions/spill have been achieved for proton
and carbon ion beams. The acceleration and spill cycle patterns currently must be fixed during the
beam tuning process, although we anticipate variable capability will become available in the future.
Additionally, radio-frequency knockout extraction was added to the synchrotron extraction line and
tuned, allowing for fast beam gating. Beam specifications and limitations, including radioprotection
limitations are summarized in table 1 [22]. For experiments requiring other ions, beam intensities
or energies, the high-energy beamline (Cave A) and the Atomic Plasma Physics and Application
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Figure 1. The layout of the accelerators and beamlines at GSI [22], including the ion sources, the universal
linear accelerator (UNILAC), the synchrotron, the FRagment Separator (FRS), and the radiotherapy research
facility (Cave M).

(APPA) beamline are available. The main control system for this accelerator monitors and operates
the major beam delivery components and the tuning of beam optics [20]. The spill cycle and beam
parameters are tuned from a beamline model and optimized manually via the main accelerator
control system (ACS) [24] before beam delivery begins.
The original, Versa Module Eurocard (VME) based dose delivery system hardware of the ACS
has been replaced with a control system with modern architecture. This architecture is also used
at the Large Hadron Collider (LHC) and includes the LHC Software Architecture (LSA) based
settings management system and a new timing system based on the White Rabbit framework [25].

Ion species*

H–Fe

Ion energies*

100 MeV/u–2 GeV/u for light ions

Spill duration (slow extraction)

1–20 s

Emittance

1π–20π mm mrad

Intensity variation*

103 to 1011 ions/spill for p+ and C6+

Maximum rigidity in SIS-18

18.5 Tm

Maximum rigidity to reach Cave M isocenter

11.8 Tm

Beam diameter

Typically 2–10 mm FWHM in air at isocenter

*Stated ranges conform to the radioprotection limits due room shielding in Cave M as well as beam scanning
capabilities.

2.2

Beamline components

One branch at the SIS-18 synchrotron facility is the Cave M beamline. This is a horizontal beamline
that is equipped with components for directing the beam and magnets for focusing the beam, as
well as the radiofrequency knockout (RFKO) system. An alternative beam path is also available,
which traverses the FRagment Separator (FRS) and branches into Cave M, can be used to deliver
radioactive ion beams. Figure 2 shows the layout of both of these beamlines, from the synchrotron
to the nozzle, located within the therapy room.
2.3

Treatment delivery elements

Several major beam delivery components are used to monitor and control the delivery of treatment
beams. These include orthogonally oriented two dipole magnets for pencil beam scanning, three
beam-position monitoring detectors, two transmission-type ionization chambers to monitor the
beam current, and a ripple filter [26], each located in the beam nozzle (figure 3). These components
are controlled by a DDS implemented with field programmable gate arrays (FPGA). To preserve
the sharp lateral penumbra of the beam, the material through which the beam traverses in the nozzle
was minimized. Specifically, the total water-equivalent path length (WEPL) of the components in
the beam, excluding the ripple filter, is only 1.71 mm.
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Table 1. Summary of the current SIS-18 accelerator specifications for the ion-beam therapy research facility
(Cave M), after FAIR Phase-0 upgrades.

Beam abort magnet

Cryring

FRS

ESR

SIS-18

Cave A
Cave M

During beam delivery, these components are controlled and read out by a TCS. The real-time
VME treatment control system (composed of control and readout module (SAM) digital signal
processors) used previously [21], was no longer compatible with the accelerator and was replaced.
The replacement TCS was adapted from the clinical DDS at the National Center for Oncological
Hadrontherapy (CNAO), as described in Giordanengo et al. [27]. A research version of the TCS is
found at both GSI and CNAO, and consists of a peripheral component interconnect (PCI) eXtensions
express (PXIe) crate (National Instruments, Austin, Texas) and FPGA cards. A description of the
DDS used in this work was reported by Lis et al. [10]. Figure 4 shows components located at the
end of the beamline.
All beam deliveries are made with their centroid location relative to the beamline’s isocenter,
which is localized with five positioning lasers mounted in the irradiation room. The maximum field
size at isocenter is 20 × 20 cm2 . The coordinate systems were based on the recommendations of the
International Electrotechnical Commission (IEC) (IEC 61217, 1996).
2.3.1

Treatment control system

The current TCS runs on the Windows operating system (version 7; Microsoft, Redmond, Washington) and is based on real-time software (LabVIEW version 16.0; National Instruments, Austin,
Texas). The TCS can also run on another commercial, real-time operating system (NXG Real-time
Module LabVIEW; National Instruments, Austin, Texas), which is used in clinics. The architecture
of the TCS closely resembles the version reported by Giordanengo et al. [27]. The delivery control
crate comprises eight PXIe field programmable gate array (FPGA) modules: six PXIe-7821R cards,
which we labeled memoFPGA, intFPGA, scanFPGA, pos1FPGA, pos2FPGA, and GSItimingFPGA
and one PXIe-7820R card, which we labeled timingFPGA. These are dedicated to controlling treatment slice loading and voxel sending, measuring the number of particles delivered, directing the
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Figure 2. Layout of the beamline from the SIS-18 accelerator to the ion-beam therapy research facility (Cave
M). Two beamlines branch out from the SIS-18, including the main line (indicated in red) and a secondary
line that traverses the FRagment Separator (FRS) to deliver radioactive ion beams. Other notable beamlines
include the cryogenic storage ring (Cryring), the heavy ion storage ring (ESR), and the high-energy beamline
(Cave A).

beam spot, measuring beam spot position, acting as a timing system interface and synchronizing
DDS operations with synchrotron operations, respectively. Additionally, there is one PXIe-7857R
card, which serves as the motion control module, which will be referred to as motionFPGA. Detailed
descriptions of the TCS can be found by Lis et al. [10] and Giordanengo et al. [27].
2.3.2

Beam-abort and beam-gating systems

Beam delivery can be stopped for two reasons. During the course of a treatment, the beam is
temporarily stopped at the end of an iso-energy slice (IES) or the end of treatment, once all beam
spots have been delivered. Additionally, if abnormal conditions arise, the delivery may need to
be prematurely and irreversibly terminated. Cave M has a beam abort system to perform these
“treatment control” and “safety” operations.
During normal irradiations, the TCS uses the beam abort system for both of these operations.
At the end of an IES, the beam is temporarily aborted, enabling the TCS to prepare delivery for the
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Figure 3. The radiotherapy research facility (Cave M) beam nozzle. Beam nozzle elements include the exit
window to the vacuum chamber, five beamline monitors and positron emission photography (PET) camera.
The PET camera has been removed and will be replace with other online beam monitoring technologies. The
dose delivery system is located behind the beam nozzle (not shown).

next IES. At the end of a treatment, the beam is permanently stopped. Additionally, the beam abort
system is activated during abnormal and unsafe conditions, such as steering magnet failure. In this
case, an interlock is set and the beam is also permanently and irreversibly aborted.
The beam abort system utilizes a fast quadrupole magnet, located at the SIS-18 extraction
channel (figure 2). The magnet rapidly shifts the beam tune towards resonance, destabilizing the
particles and pushing them out of the beam path. The beam is then dumped in the synchrotron, so
that recovery of the spill is not possible. Cave M also contains a beam gating system. The beam
gating system is used for rapid, temporary beam interruption during the course of a spill. One
example is beam gating synchronously with organ motion.
Beam gating is performed using RFKO extraction which is now utilized for rapid beam interruption and recovery and can also be used for beam abort functionality. In order to rapidly gate
beam delivery, RFKO extraction is momentarily interrupted by switching the RFKO exciter off and
then on again to resume the extraction. In addition, a frequency shift is introduced on a synchrotron
cavity, moving the beam out of tune and effectively preventing extraction. This allows for beam
gating and recovery multiple times during a spill, without requiring a fast kicker magnet in the
beam extraction junction, as present in most clinical facilities. In contrast to fast kicker magnets,
frequent and rapid gating with RFKO does not pose a risk of gating failure due to overheated power
supplies for the magnets. On the other hand, RFKO beam pauses cannot fully block the beam and
a small number of particles will leak through (as seen in figure 8). During normal operation, the
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Figure 4. (A) A schematic of the beam nozzle for ion-beam therapy research at GSI. The nozzle contains
several beamline elements, including (a) horizontal and (b) vertical scanning magnets, (c) the vacuum tube,
(d)–(i) five beam monitors and a ripple filter. All distances are relative to the isocenter position (indicated
with a red dot). The patient couch is movable and found past the isocenter position. (B) A schematic
representation (not to scale) of the exit window design. The exit window contains a double layer of polyester
film and support mesh. (C) A close up of the exit window, beam monitors, including two position detectors
((d) MWPC1 and (h) MWPC2), and three transmission-type ionization chambers ((e) IC2, (f) IC1 and (g)
IC3), and (i) a ripple filter, including distances from isocenter (in mm). The isocenter location is marked
with a red ‘×’.

DDS triggers both systems automatically, as described in section 2.7.1. The abort system can also
be triggered manually to gate the beam and pause the delivery.
2.3.3

Scanning magnets

Table 2. Specifications of the scanning magnets and their power supplies used in the GSI radiotherapy
research facility (Cave M).

Characteristic

Unit

𝑿 magnet

𝒀 magnet

Magnet gap

mm

130

170

Magnet effective length

mm

531

1209

Overall length

mm

600

1290

Max deflection angle

◦

1.45

3.30

Maximum field strength

T

0.38

0.38

Coil resistance

mΩ

63

154

Coil inductance

mH

9.2

33

Maximum current

A

400

400

Maximum voltage

V

±368

±330

Current ramp rate

kA/s

±40

±10

Scan speed for 280 MeV/u for C6+

m/s

35

17

Unipolar

Unipolar

Power supply polarity

The communication interface for the scanning magnet power supplies was also redesigned. The
scanning magnet power supply set values are communicated via a digital serial optical fiber cable
and are sent at 20 Mbit/s with 20-bits per set value. The conversion of the spot position from lateral
position (mm), from treatment plans, to power supply set values (current) for the scanning magnets
are calculated using an analytical calibration formula. Parameters used in the conversion formulas
are stored in files that are loaded during DDS configuration and transmitted to the power supplies
through the scanFPGA module of the TCS. The equations for this conversion are as follows:
𝐼 𝑥 − 𝐼0 𝑥
𝑋 (mm) =
+ 𝑋0
𝐹𝑥 (𝐸)
𝑌 (mm) =

𝐼 𝑦 − 𝐼0 𝑦
+ 𝑌0
𝐹𝑦 (𝐸)

where 𝐼 𝑥 and 𝐼 𝑦 are deflection currents, 𝐼0 𝑥 and 𝐼0y are energy dependent correction factors,
𝐹𝑥 and 𝐹𝑦 are energy dependent rigidity correction factors, and 𝑋0 and 𝑌 0 are magnet offset
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The scanning magnets in Cave M function by steering a pencil beam to each spot position via the
raster scan technique, as described by Haberer et al. [4]. The center of the horizontal (𝑋) and
vertical (𝑌 ) magnets are located 8 826 mm and 7 800 mm from the isocenter, respectively, as seen
in figure 4. The scanning magnet power supplies and calibration were retained without alteration
as originally installed in 1995. Table 2 lists selected characteristics of the scanning magnets and
power supplies.

correction factors. The GSI scanning magnet power supplies are unidirectional, with currents of
up to 400 A. The nominal horizontal beam scanning velocity in the isocenter plane is 27.5 mm/ms
for 430 MeV/u carbon beams. The beamline is vertically inclined by −2.203◦ and horizontally by
0.649◦ , accommodating the unipolar scanning magnets. This was designed as a safety feature for
therapy, so that the beam will pass 300 mm above the isocenter and thus miss the location of a
patient in the event of a scanning magnet failure. The vertical magnet strength limits the beam
rigidity that can hit the isocenter to Bρ < 11.8 Tm, and to Bρ < 8.9 Tm for the maximum scan field
of 200 × 200 mm2 at isocenter.
Exit window

The exit window (figure 4C) is found at the end of the evacuated segment of the beamline, which
encloses a vacuum, typically at 10−8 mBar. The usable area of the exit window measures 210 ×
210 mm2 , as required to create large enough lateral area for therapy. The inner layer of the
vacuum window is composed of 100 μm, 14 g/m2 polyester film (HOSTAPHAN RN 100; Mitsubishi
Polyester film GmbH, Wiesbaden, Germany) that is supported by a 120 μm thick, 58 g/m2 highstrength synthetic fiber mesh (Kevlar 49 Style 120; Fa. Cramer & Co, Heek, Germany), as seen
in figure 4B. Behind these materials, there is a second layer of polyester film and high-strength
synthetic fiber, with the same properties, which is spaced at a few mm apart from the first layer,
and contains pre-vacuum. The second layer serves as a therapy safety feature and creates a tighter
vacuum. The front face of the exit window is located 1050 mm from isocenter.
2.3.5

Nozzle detectors and readout algorithms

Five detectors are mounted in the nozzle (figure 3). Three of these detectors are parallel plate
ionization chambers — IC1, IC2, and IC3 — and are found 880, 925, and 835 mm from the
isocenter, respectively. The ICs are ArCO2 gas filled (80% Ar and 20% CO2 by mass) ICs, which
provide the beam intensity signal (a current that is proportional to particle rate). The remaining
two detectors are position sensitive multi-wire proportional chambers (MWPC), which provide
beam spot position information. The two MWPC detectors, denoted by MWPC1 and MWPC2, are
located 970 mm and 790 mm from isocenter, respectively. Three of these detectors (IC1, IC2, and
MWPC1) are currently used for beam monitoring. IC3 is used by the ACS for beam diagnostics and
its signal is digitized independently of the DDS by a current to frequency converter. These detectors
have been retained without modification from the original Cave M facility, where redundant dose
and beam position monitors were installed to fulfill the safety requirements for patient therapy;
however, the electronic readout systems for these instruments were replaced.
The ICs have 210 × 210 mm2 large area anodes and cathodes of 54 μm thick nickel coated
polyester mesh. The two cathode planes are symmetrically arranged around the anode, with 10 mm
gaps in between. The ICs are housed in an aluminum frame with 25 μm metallized plastic windows.
Both ICs operate at a potential of 1.8 kV.
The IC1 current is read out by a fast current-to-voltage amplifier (DLPCA-200; FEMTO,
Berlin, Germany) and the output voltage (−10 V to 10 V) is sampled by a 14 bit analog to digital
converter (ADC) card (NI PXIe-5172 FPGA). The ADC card digitizes at 125 MHz rates, which is
down-sampled to 1 MHz. The current from IC2 is read out with an application-specific integrated
circuit (ASIC) chip (TERA09; DE.TEC.TOR Srl, Torino, Italy). This chip based on the TERA06
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2.3.4

where 𝑃 is the number of particles, 𝐺 Rel is a ratio of the relative gain between the two ICs, 𝐹 (𝑋 𝑏, 𝑌 𝑏)
is a spatial uniformity correction lookup table, 𝑘 (𝐸) is an energy-dependent conversion factor, 𝑘 TP
is the temperature and pressure correction and 𝑘 QAfit is a correction factor derived from daily quality
assurance measurements.
The MWPC detector is read out by the pos1FPGA, which analyses the signal distribution from
all wires and determines the relative lateral beam position and spot size of each beam spot by
calculating the center-of-mass and standard deviation [33] with the following equations:


𝐾𝑥Pos · 𝑋 𝑏 − 𝑋0Pos 𝑁𝑐ℎ𝑋Pos − 1
𝑋Pos (FPGA units) =
+
100
𝑝𝑐ℎPos
2


𝐾 𝑦 Pos · 𝑌 𝑏 − 𝑌 0Pos 𝑁𝑐ℎ𝑌Pos − 1
𝑌Pos (FPGA units) =
+
100
𝑝𝑐ℎPos
2
where 𝐾𝑥Pos and 𝐾 𝑦 Pos are constant conversion factors for converting between mm and relative
units used internally by the FPGA, 𝑋0Pos and 𝑌 0Pos are the offset of the position detector in the
𝑋 and 𝑌 directions, respectively, pchPos is the pitch of the detector, NchX Pos and NchY Pos are the
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and TERA08 [28] chips, developed at the University of Torino, which are used at CNAO and
MedAustron [29] respectively. As is done at CNAO, the second IC detector’s counts are scaled
down by a factor (Grel ) of 1.1: without this scaling factor, both ICs would alternate in signaling
beam spot progression. Additionally, IC2 serves as a redundant detector in the case of IC1 failure.
The ASIC chip contains 64 charge-to-frequency converter channels [30]. The charge collected
in the second ionization chamber (IC2) is accumulated by one of the 64 channels of the ASIC chip
and converted to counts. The 32-bit charge counter of these channels is read out with 1 MHz rate
by the intFPGA, at the same rate as for the ADC card from IC1.
The currents from all of the wires of each the MWPC position detectors are read out with four
ASIC chips. A modular board has been designed for the position detector readout, containing up to
4 TERA09 chips. This board reads out the signals from the MWPC, which contains 224 wires in
the 𝑋-plane and 224 wires in the 𝑌 -plane. Each wire is electronically connected to a neighboring
wire for noise reduction. The wires within the MWPC are each 50 μm diameter with 1 mm spacing
between wires.
A gas electron multiplier (GEM) strip chamber detector [31, 32] is under development as the
new, primary position detector. MWPC2 has been previously used as a redundant position readout
for safety purposes during radiotherapy. For diverse and redundant readouts, one MWPC will be
maintained. It is anticipated that the GEM detector will be considerably faster than the MWPC as it
amplifies the fast electron signal by a factor of 10 to 100 through the gas amplification at the GEM
layers while suppressing the slowly drifting positive ions. The GEM design has 256 strips per plane
with a 1 mm pitch and requires one readout board per plane. Comprehensive tests on this detector
are planned for 2021.
The IC counts are read out by the intFPGA, and when the set number of counts is reached, a
signal is sent to the DDS controller to progress to the next beam spot. Particles numbers for each
beam spot (extracted from the treatment plan) are converted to IC counts through the following
equation:
𝑃 · 𝐺 Rel · 𝐹 (𝑋 𝑏, 𝑌 𝑏)
Counts =
𝑘 (𝐸) · 𝑘 TP (𝑇, 𝑃) · 𝑘 QAfit

number of channels of the position detector, 𝑋Pos and 𝑌Pos are the 𝑋 and 𝑌 coordinates (in detector
units) of the position detector, and 𝑋 𝑏 and 𝑌 𝑏 are the IEC coordinate 𝑋 and 𝑌 positions (in mm)
of the isocenter, respectively. The first term in the parentheses of the two equations converts the
isocenter position into detector units, and the second term shifts the value to the expected multi-wire
number. These values are scaled by ×100 for sub-millimeter position sensitivity. The pos1FPGA
also provides position feedback to the scanning system for lateral position control of the beam.
2.3.6

Ripple filter

2.3.7

Range shifters

A portable binary range shifter is available to shift the beam penetration range. Following the
upgrade of the SIS-18 ACS, treatment directed energy variation, performed by the synchrotron,
was eliminated. This lost functionality provided 250 beam energy steps. In future phases of the
FAIR upgrades, this capability will be restored; however, in the interim, the binary range shifter is
available to shift the particle range and deliver dose volumes. The range shifter is composed of 10
precisely cut polyethylene (PE) plates, each roughly doubling in size, to vary the WEPL delivery
depth up to 100.2 mm. The plates are 0.063, 0.125, 0.235, 0.474, 0.951, 1.90, 3.80, 7.69, 15.46,
and 30.91 mm water-equivalent thickness (WET). An additional 38.6 mm WET block can be added
for additional depth. The range shifter is placed behind the ripple filter, with the thickest plate as
close to isocenter as possible. Further details were reported by Simeonov et al. [34].
2.4

Motion mitigation system

The motion mitigation system is an optional unit, used for motion mitigation studies. The motion
mitigation capabilities are produced by two FPGAs, motionFPGA (PXIe-7857R, National Instruments, Austin Texas), and memoFPGA (PXIe-7821R, National Instruments, Austin Texas), which
monitor target motion and redirect delivery to the measured motion position, respectively. The
motionFPGA contains both analog and digital I/O and can be adapted to a variety of detection
systems that deliver diverse forms of data, such as position in space, 1D motion traces, or externally
pre-computed motion state information. Implemented motion mitigation strategies include conformal motion-synchronized dose delivery, gated delivery, and internal tumor volume [35] rescanning
treatments. Tumor tracking, as described by Saito et al. [36], will be implemented for further motion
mitigation studies. More information on the motion mitigation system was reported in Lis et al. [10].
2.5

Timing system and beam request processor

The timing system is used to synchronize beam delivery to the accelerator spills. Timing signals are
sent from the timing system interface (timingFPGA) and used within the other FPGAs to synchronize
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A ripple filter is placed within the beamline, located 600 mm from the isocenter, to broaden the
Bragg peak maximum region of ions to more than 2 mm. Two ripple filters are available, which are
composed of 2 mm thick and 3 mm thick polymethyl methacrylate (PMMA) plates with a periodic
structure of fine grooves with a well-defined ridge shape. The 3 mm ripple filter is mainly used
during carbon ion therapy experiments. The design of the ripple filters was reported by Weber and
Kraft [26].

Figure 5. Timing events from the accelerator, where ‘Begin Extraction’ triggers the beginning of a spill,
‘End Extraction’ triggers the end of a spill, and both ‘End Extraction’ and ‘End of Slice’ signals turn on the
‘Beam Abort’ signal until a spill is completed or at the end of a treatment. These signals are recorded along
with motion phase changes and can be used to reconstruct delivered doses from delivery log files.

2.6

Pre- and post-treatment

Treatment plans are created through two methods: simple, mono-energetic rectangular plans with
homogenous fluences are generated from a plan creation tool, while 3D geometries are created
with the research treatment planning system at GSI, TRiP4D [37]. TRiP4D is an extension of
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beam delivery signals between the FPGAs. An additional software layer has been added to the
timing system interface to allow for communication between the beam request processor of the
synchrotron and the DDS while maintaining the timing events from the implemented DDS. This
layer is located in the GSItimingFPGA and serves as a compatibility layer to allow the rest of the
DDS to be used at multiple centers without modification. Spill patterns are pre-set by the ACS
during machine tuning, along with other machine parameters, such as focal spot size and particle
intensity, and only signals for the start and end of treatment are sent to the central accelerator during
delivery.
The developed beam request software communicates beam progression signals with the ACS.
Signals are sent via a transmission control protocol (TCP) to the ACS, which triggers the beginning
and end of beam delivery with the ‘Start Treat’ and ‘End Treat’ signals. Spill patterns from pre-set
beam parameters (spot size, energy, particle flux) are delivered until the ‘End of Treatment’ signal
is received. For each spill, synchrotron timing events trigger the stop and start of a spill through
the ‘Begin Extraction’ and ‘End Extraction’ signals. These external signals trigger ‘BeamOn’
and ‘BeamOff’ signals internally to synchronize the DDS FPGAs during delivery. ‘NextCycle’
and ‘RepeatCycle’ signals are generated from the DDS to signal the accelerator to repeat a spill
or transition to the next energy, respectively. At the end of an IES and in between spills, the
fast-extraction-stop quadrupole magnet is activated until the end of that spill, as seen in figure 5.
Additionally, in physics mode (beam delivery without a treatment plan) the beam request system
interface can request one beam spill, ‘Trigger Request’, or a repeating pattern of spills, ‘Continuous
request’. During plan delivery, these modes are disabled and the beam request begins automatically
once a treatment plan is loaded and sent. As described in section 2.3.7, only single energies could
be pre-set with the current ACS. However, the existing CNAO beam parameter code protocols (socalled CycleCodes) are still maintained, anticipating for future multi-energy switching capabilities
at GSI. These CycleCodes [27] are hexadecimal codes that represent accelerator energy settings for
each IES. To deliver 3D volumes at GSI, the CycleCodes were converted to settings for the binary
range shifter, allowing range modulation.

2.7

Description of verification tests

Online and offline tests were performed during several stages of development to verify the functionality of each subsystem. The offline subunit tests are summarized in table 3. Signal transmitting and
receiving, as well as the correct calibration of the scanning magnets and beam line detectors was
confirmed through measurements with dedicated testing software. Timing events, treatment progression and beam request functionality were confirmed on a digital oscilloscope (R&S RTB2004;
Rohde & Schwarz, Munich, Germany) and through timing system log file analysis. Subsequently,
the integrated functionality of each sub-system was also confirmed offline by delivering treatments to completion with simulated beam signals and then assessing accuracy in DDD files and
treatment logs.
Online subunit tests were performed to visualize the performance of each beamline component
and end-to-end tests were performed to test the entire TCS during delivery (table 4). The beam
output, or the absorbed dose to water at isocenter, was measured with a farmer type ionization
chamber and an electrometer (Unidos E, PTW, Freiburg, Germany). Additionally, each batch of
radiochromic films (Gafchromic EBT3; ISP, Wayne, New Jersey) was calibrated by delivering a
pattern of eight squares of increasing particle fluence to a film placed behind 2 cm of PMMA
plastic [43]. A calibration curve, converting optical density values to particle fluence was then
applied to each film, using an image analysis software, (ImageJ version 1.52a; National Institute
of Health, Bethesda, Maryland). A 60 × 60 cm2 square profile was delivered three times to a 2D
ionization chamber array detector (Octavius VDR 1500; PTW, Freiburg, Germany) to measure
the absolute dose and delivery constancy (calculated with standard deviation of the absolute dose
measurements). Experiments were performed by delivering simple geometries and spot patterns
to the detectors. Additionally, cubes and ellipsoids were delivered to confirm the performance
of the range shifter and the capability to deliver multiple depth plans uniformly. In addition to
online performance verification tests, the performance of individual beamline components was also
studied experimentally.
End-to-end tests were performed, including field homogeneity, beam reproducibility, dosimetric precision and delivery speed. Field homogeneity tests were performed by delivering a
uniform 60 × 60 mm2 square field to radiochromic films, placed behind 2 cm of PMMA plas-
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TRiP98 [38, 39] that considers temporal changes to patient anatomy during treatment plan creation.
The plans and, in the case of motion-compensation deliveries, plan libraries were designed with
4D-optimization to target volumes [40], which results in a conformal treatment plan. Robustness
has also been incorporated, allowing for minimizing the effects of delivery degradation due to
range uncertainties, patient set-up errors and uncertainties in anatomy changes due to respiratory
motion [41]. TRiP4D has been optimized for carbon, oxygen and helium ion beams, but can be
extended to include additional ions. Additionally, the DDS has been designed to accept Digital
Imaging and Communications in Medicine (DICOM) standard and VOXELPLAN format [42]
treatment plans and can easily be modified for additional plan format options.
During delivery, the data from the beam monitors and scanning magnets for each delivered
spot is logged into binary dose delivery data (DDD) log files. For motion-synchronized deliveries,
detected motion is logged into binary motion monitoring data (MMD) files. These files can be fed
back into TRiP4D for 3D and 4D dose reconstructions.

Table 3. Summary of offline subunit verification tests and the relevant analysis tool for each portion of the
dose delivery system and integration tests to the beamline components. SLD refers to slice file data and DDD
refers to the dose delivery data.
Subunit
Beam request
Timing system

Beam abort
Scanning magnets

Ionization chambers

Analysis tool

Triggers a single spill

Virtual beam spill visualized on oscilloscope

Continuous beam request sent

A series of spills visualized on oscilloscope

Triggers start and end of treatment

A series of spills visualized on oscilloscope

Timing events sent to other FPGAs

Timing log file analysis

Triggers correct change total thickness

Set manually and confirm total thickness

Delivers simple plan of several depths

Confirm CycleCodes and depths correspond

Boolean trigger from application

Visualized on oscilloscope

Communication with power supplies

Visualized on hall probes

Coordinates correct
Power supply calibration — spot position
correct

Set values with an application

Simulates signal to amplifier

Observe signals

Signal counts calibration

Treatment log file analysis

Signals spot and spill progression

Observation in DDD files

IC1 as dominant detector

Observation in DDD files
Observation of motion signal from motion
sensor in the motion monitoring system

Connection to external motion signal
Motion mitigation system

Multi-wire position chamber
readout
Treatment plan handling

Set values with an application

Detection of motion

Observation of motion phases in the DDS

Sends of motion phases

Receiving phases treatment in log files

Spot position as expected

Set values with an application

Loads entire plan libraries

SLD file analysis

Sends single spots
Sub-plan switching when motion phase
changes

DDD file analysis
DDD file analysis

tic. The homogeneity was calculated with the homogeneity index (HI), using the equation
HI = (Hmax − Hmin )/(Hmax + Hmin ) × 100 [27]. Reproducibility measurements were performed
by delivering the same square field multiple times to a farmer type IC chamber. Additionally, 3D
dosimetry was performed to measure doses across a uniform square volume. The HI was measured
across several depths. Treatment delivery speed was assessed by delivering a square shaped plan
with ramped particle intensities for each line, starting at 500 000 particles per beam spot and decreasing to 100 000 particles per beam spot. The 2D ionization chamber array detector was used for
several measurements, including uniformity measurements, and is a standard tool for experiments
in Cave M.
2.7.1

Beamline component tests

The effect of the range shifter on the beam spot profile was characterized by delivering 25 beam
spots, each to a different range shifter depth, varying from 0 to 100.18 mm. To perform this, a 25
beam spot grid plan was delivered to a radiochromic film. The film was calibrated in the image
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Range shifter

Test

Table 4. Summary of verification tests performed at GSI. The described treatment plans were designed to
test individual functionalities.

Plan

8 spots in 1 slice

6 lines, each in
6 slices
25 spots plan at
various depths
Uniform squares
Ramp square

Test

Beam request

Delivery completion

Scanning

Spot position in correct location

Scanning, position detectors

Correct orientation

Detectors

Multiple spots delivery

Gating system

End-of-treatment beam abort

Scanning magnets

Spot position accuracy

Timing system

Synchronized delivery of multiple spills

Beam request

Slice change when triggered

Gating system

End-of-spill beam abort

Gating system

Gating related to motion handling

Treatment plan handling

Capability to deliver plan non-sequentially

Range shifter

Beam spot size and shape at different depths

End-to-end

Beam reproducibility

End-to-end

Uniformity at several depths

Scanning magnets

Scanning magnet speed limits and accuracy

analysis software, by applying a gray-value to particle fluence correction, and corrected for the
linear energy transfer (LET) dependence response for C6+ . To determine the beam spot sizes, the
full width half maximum (FWHM) was determined and the beam spot profiles were fit to double
Gaussian functions. This data was used to update TRiP4D for deliveries using the range shifter.
The functionality of the MWPC was tested by delivering single beam spots and correlating the
positions and fluence profiles measured in the detector with spot positions found in the DDD files
and the profiles measured with a digital oscilloscope card (PXIe-5172; National Instruments, Austin,
Texas), respectively. Additionally, the speed of the beam spot position readout was characterized by
calculating the internal deadtime and comparing the determined position with the delivery duration.
The readout for IC1 was tested by delivering a 2.5 Gy square-shaped plan to a calibrated farmer
chamber (PTW 30010; PTW, Freiburg, Germany). The calibration of the beamline IC chambers
was calculated and confirmed using an in-house developed software. The functionality of the
redundant readouts of IC1 (ADC) and IC2 (TERA09) was confirmed with C6+ beams by evaluating
the difference in electric charge between measured beam spot counts and planned beam spot counts
matched for both ICs. Additional validation testing studies are ongoing.
Tests were also performed to determine the maximum delivery speed. Delivery speed is limited
by scan speed and position-detector-readout speed, which dictates the minimum particle number
when creating treatment plans. Two square fields, each with increasing particle numbers for each
row of the treatment plan in either the horizontal or the vertical direction, were delivered with
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5 spots in 5 slices

Subsystem/system

3

Results

Tests to confirm the functionality and reliability of Cave M were performed and are reported
here. Preliminary tests for each beamline component were performed offline (without beam) and
online, using the available ion beams (Ar+18 and C6+ ). Successful signal transmission, reception
and proper calibration were confirmed for each sub-system through the analysis tools described in
table 3. The hardware and software to the beamline components have been successfully integrated
into the experimental therapy beamline at GSI. The pass/fail tests described in table 4 all passed.
Further results for tests on beam spot size and shape at different depths, beam reproducibility and
uniformity, spot position accuracy, gating and beam abort tests are presented below.
Beamline component functionality tests (see section 2.7.1) were performed successfully and
test case plan libraries were delivered to completion. Timing system events, including ‘Start Treat’,
‘End Treat’, ‘Start Extraction’, and ‘End Extraction’ were confirmed to be transmitted to the beam
request processor. The scanning system and detector systems were found to be properly calibrated
and in the correct orientation. At the time of writing, signal degradation due to noise has limited
the position detector readout speed, and the ASIC readout cards are being redesigned.
The beam spreading when using the range shifter was characterized for C6+ and p+ beams by
delivering 25 spots at 25 different range shifter settings (figure 6). The beam spot FWHM for each
range shifter depth varied from 3.15 to 7.15 mm for C6+ and 8.0 to 19.4 mm for p+ , corresponding
to the range of 0 to 100.8 mm in water. FWHM for each energy step was interpolated with a linear
fit curve and resulting beam spot sizes for each energy step were used during log file based dose
reconstructions. The base data of TRiP98 will be updated accordingly.
The calibration of the beamline IC chambers and redundant readout functionality was confirmed. Beam position detection accuracy was assessed by comparing measured beam spot positions
on a radiochromic film with planned positions. Accuracy was found to be within 1 mm in the horizontal and vertical directions, but these values will deviate for other species and energies, with very
low magnetic rigidity beam most likely showing lower accuracy. High noise due to the design of
the position detector readout remain, and portions of the board are being redesigned.
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carbon ion beams. The actual beam spot positions in the DDD log files were compared to expected
positions in the slice delivery (SLD) files. Position accuracy was calculated by calculating the
distance to agreement for each spot.
The performance of the fast (RFKO) gating system and the beam abort system was benchmarked. Two types of tests were performed manually to characterize the DDS response to anomalous losses of beam. First, the functionality of both the quadrupole beam abort and the RFKO
gating system was tested by connecting the trigger line of the quadrupole magnet extraction and,
respectively, the RFKO system, to the timingFPGA and manually triggering beam disruption with
a virtual Boolean switch. Subsequently, the speed of both modes of beam disruption and recovery
were assessed to determine the rapid gating performance capabilities of the gating system during
treatment deliveries. These tests were performed by manually triggering the RFKO extraction off
and on in the same manner, while measuring the particle fluence (in μs) for single spills. The digital
oscilloscope card was used to measure the particle intensity at 1.25 MHz.

Figure 7. Beam spot position accuracy for a cube plan delivery, delivered with 240 MeV/u carbon ions,
using the range shifter. The difference between planned and recorded current values in the 𝑋 (orange) and 𝑌
(blue) directions are indicated.

The scanning direction and calibration was confirmed by manually setting the magnet set
values to various positions. Without position feedback, the scanning magnet set values were found
to be accurate within 1 mm, and maximum deviations were found to be 0.99 mm ± 0.1% and
0.99 mm ± 0.06% for the vertical and horizontal scan directions, respectively, as seen in figure 7.
The scanning magnet accuracy was 0.5 mm for the ramp square delivery. The accuracy of delivery
is expected to increase once position feedback from the position detections to the scanning magnets
is in place. Minimum detector counts are currently set to 20 000 particles per spot for faster
delivery: lower-weighted beam spots can create a bottle-neck in irradiation speed due to limitations
in measurement precision.
The usable maximum energy is limited by ion species and by scanning magnet strength. The
maximum energy to deliver ions to isocenter and across a 10 × 10 cm2 scan field were calculated
for various ion species and are summarized in table 5.
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Figure 6. Beam spot sizes for 25 range shifter settings, delivered with carbon ion beams.

Table 5. Maximum energies for various ions, with respect to scanning magnet limitations.

Ion

Delivery to isocenter

Delivery across 10 × 10 cm2 scan field

P+

2 000 MeV

1 850 MeV

Fe26+

950 MeV/u

575 MeV/u

C6+

1 100 MeV/u

680 MeV/u

Figure 8. Beam gating by halting the radiofrequency knockout extraction. The beam intensity was measured
at 1.25 MHz using the beam nozzle IC (red) and readout by an amplitude to digital converter (ADC)
oscilloscope card. Particle intensity is shown before and after activating the beam gate signal (blue).

Dosimetry was performed prior to performing other beam deliveries. Absolute dosimetry
measurements with a farmer chamber resulted in a dose reproducibility of ±1.07% for 2.5 Gy
deliveries, where standard deviations of <3% are considered acceptable. Field homogeneity of a
square, delivered to a depth of 20 mm into PMMA was within 4.9% in the horizontal direction and
4.7% in the vertical direction (figure 9a). Gamma index analysis pass rates for cube deliveries,
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The functionality and performance of the beam abort and beam gating systems was confirmed.
The beam abort system was activated when triggered, including at the end of each slice and until the
completion of each spill, as expected. RFKO gating tests for multi-gating capabilities determined
that reduction to 5% of the full beam intensity was achievable within 2 ms, and full beam disruption,
to 1% intensity, was achievable within 20 ms, as seen in figure 8. The minimum gate duration was
determined to be 10 ms. Further RFKO tuning will be performed to improve beam gating speeds.
The beam ramping was optimized to achieve these results. These rates were sufficient to conduct
motion-synchronized irradiations. Comparable clinical fast gating systems, such as that at CNAO,
are capable of complete beam disruption within 150 μs.

comparing measurements with the 2D IC array detector to log file dose reconstructions, were found
to be 100% (figure 9b), and time to deliver the cube was 423 s. The slight misalignment between
the two data sets in figure 9b may be due to limitations to the resolution of the 2D IC array detector
and imperfect tuning of the beam spot prior to experiments.

4

Discussion

We have re-designed and upgraded the GSI radiotherapy research facility (Cave M) during the
FAIR shutdown period from 2016 to 2018. We designed the beamline to maintain clinical specifications and have adapted and extended a clinical dose delivery system (DDS) from CNAO, for
4D capabilities, to allow for experiments in clinical-like conditions. Tests have been performed
to confirm functionality and consistent performance of the beamline elements and the DDS. The
presented information is also intended as a reference for external users to determine the possibility
of conducting research at GSI and applying for beam time through the GSI BioPAC [44]. The major
finding of this study is that the updated Cave M has been successfully characterized and is now
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Figure 9. Uniformity measurements of a 60 × 60 mm2 square, placed behind 20 mm of PMMA plastic,
measured with a (a) radiochromic film and the horizontal uniformity profile; (b) measurements of a 60 × 60 ×
60 mm3 cube, reconstructed from delivery log files and overlaid with the respective 2D ionization chamber
array detector measurement (white boxes).
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available for users. The new DDS was used to perform the first experiments on biological samples,
including uniform spread-out Bragg peak irradiations of culture flasks with protons and carbon ion
beams, and online microscopy experiments with protons, carbon and iron ions.
The implication is that researchers may exploit this new research infrastructure to pursue
new avenues of research. Cave M has been developed in such a matter that continuous upgrades
will allow for performing innovative clinical research, beyond the capabilities of current medical
accelerators. This will allow for testing innovative new therapy methods in conditions beyond the
limitations of clinical lines, but is not limited to therapy research. GSI offers multiple modes of
beam extraction, including fast extraction, slow extraction and radiofrequency knockout extraction,
and a broad range of beam energies, which allows for testing novel delivery methods. High dose
rates and a broad range of particle energies will allow for studying Flash therapy [6]; multiple ion
sources allow for mixed beam irradiations [45]; the alternative beam path, through the FRS allows
for radioactive ion irradiation [7]; rapid gating and position feedback will allow for testing motion
mitigation strategies, including tracking and conformal, motion-synchronized delivery [10, 36, 46].
The Cave M layout is not the final design, but the current stage in the continuous upgrades as part
of FAIR-GSI phase-0. With further upgrades, additional capabilities will be possible, including
dynamic intensity control [47] and fast beam energy switching.
This work presents, for the first time, on the upgrades to the original Cave M design, including
a comprehensive description of the updated beamline and the TCS for delivering arbitrary dose
volumes. The results of this study are comparable to performance specifications of clinical accelerators, such as CNAO [33, 48] and NIRS [49]. At CNAO, commissioning results revealed that all
beam spots could be delivered within <1.5 mm of the expected positions (without position feedback) and with particle fluence accuracies of <2.5%. The resulting dose distributions were 100%
gamma index pass rates for 3%/3 mm criteria when delivering a representative patient plan [48].
The time to deliver a 60 mm diameter sphere, with carbon ion beams, at CNAO was found to be
223 s, excluding the time required to prepare the accelerator before treatment. At NIRS, commissioning results found that the difference between measured and expected beam spot positions was
< ±0.3 mm. Measured doses were within ±2% of the expected dose [49]. Typical delivery times
are not noted in the literature, however particle intensity and scan speed limits suggest around ×10
faster deliveries [50]. Our results reveal a particle position accuracy of <1 mm, a particle fluence
accuracy of <1.07%. The time to deliver a 60 × 60 × 40 mm3 cuboid was found to be 423 s. By increasing particle fluences during delivery, delivery speeds at Cave M can be theoretically increased
by a factor of 10. In order to perform Flash experiments with proton and carbon ion beams, particle
rates of 1013 s−1 and 1010 s−1 , respectively, will be required [6]. With the continued FAIR upgrades
to the SIS-18, these rates will be achievable. Beam nozzle intensity and position monitors are in
principle compatible with Flash dose rates, but research into optimal dosimetry is ongoing.
This work has several strengths. First, a majority of the features of Cave M that were developed
for clinical use during the pilot project are maintained, and the DDS has been adapted from the
clinical ion therapy facility CNAO. This is a major advantage because the beamline components
were designed to clinical standards [13, 27], and the beamline is structured so that beam monitoring
components can be inserted. Further, a majority of the safety interlocks are already in place, so as
each upgraded element was implemented, and as new therapy methods are developed, the safety
and beam monitoring strategies can be directly developed as well. Another strength is that a broad
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variety of tests were performed to validate that we have met design specifications in these upgrades.
This study was performed on multiple ions, at multiple particle intensities, and each component was
tested extensively offline before performing online and end-to-end tests. Though the tests described
here are not exhaustive, they represent many tests that are required to confirm the performance of
the facility for radiotherapy research studies. Finally, several of the updated components, including
the DDS and the ASIC readout chips, are commercial components. This ensures the reliability of
these components, allows for straightforward updates and modifications, as well as documentation
on the hardware and underlying software and technical support.
One limitation of this work is that we do not give an in-depth description of each component
of the beam delivery system. Here, we provide only brief summaries and example test results.
This is not a major limitation because detailed accounts and exhaustive tests will be provided in
other studies. Another limitation is that this study has been written at a time when some beamline
components are in the preliminary stages of testing or are still being developed. The readouts
for the MWPCs and GEM detectors have not been fully implemented, so online beam position
was not available, and the RFKO gating system has not been fully tuned. These components are
expected to be available in the next couple of years. This is not a major limitation, as the accuracy
of the scanning magnets allowed for delivering beam spots within ±1 mm of the planned position
without positions detector feedback. Further, the beamline detectors have been confirmed to deliver
accurate irradiations, as the beamline detectors have been previously used for therapy and only their
readouts have been modified. Additionally, only single energies are available for experiments and
a range shifter is used to deliver tumor volumes. The range shifter produces significant particle
scattering, due to the air gaps between each plate. Multiple energy deliveries are not anticipated
at this time, but a new range shifter will be developed to reduce beam scattering. However, this is
not a major limitation, as delivering dose volumes is still possible, and increases to the beam spot
size for each range shifter setting has been measured and implemented into the treatment planning
system. Finally, the delivery system also can already deliver full treatments to the requirements of
most users, and updates on the status of development can be provided.
Cave M is now available for pre-clinical research experiments. Prospective users should be
aware of the current status, limitations, and the planned future upgrades. The online positron
emission tomography (PET) camera that was used during the GSI pilot project is currently not
functional. The entire system for the online PET system [51] has been removed and the PET
imaging components have become outdated. The PET system will be replaced for the study of
radioactive beams within the ERC Advanced Grant — BARB [52]. In the future, a hybrid monitor
for prompt gamma ray imaging and PET will be used for online beam monitoring of the secondary
particles of four beta emitters (C-10, C-11, O-14, and O-15). These aspects may be potential
obstacles for users in the near term and should be available in the coming years. Interested users
should contact the Biophysics department at GSI for the beamline status.
In the future, the beamline components will undergo several more updates to increase delivery
speed. New power supplies for the scanning system will be implemented, which can double the scan
speeds. Additionally, the two scanning magnets will be updated to three smaller and faster ones.
The current magnet system, a very large vertical scanner, will be divided into one dipole, responsible
for tilting the beam into the isocenter, and one scanning magnet, responsible for directing the beam
during treatment. The scanning magnet will be considerably smaller due to the smaller scanning

5

Conclusion

The ion-beam therapy research facility described in this study has been updated for performing
experiments under clinic-like conditions. Cave M has re-opened in 2020 to external users. The
layout and specifications for each beamline component have been described. The performance
testing results confirm that each component performs to clinical specifications. Cave M will
provide for a near-ideal infrastructure and environment for research on novel radiation therapies
with heavy ion beams.
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angle. Both scanning magnets will be controlled by bipolar power supplies, and will be designed
for a smaller inductivity, allowing for faster operation. The new system can be used later for the
scanning system at the FAIR BIOMAT beamline [35], as the size of the magnet allows for scanning
higher energy ions. The intensity control loop will be characterized and calibrated to achieve a
stable and constant extracted intensity. Additionally, new detectors, including the GEM position
detector, will enhance precision and beam intensity and position measurement speed. Finally,
ongoing updates to the SIS-18, in preparation for the FAIR project, aim to increase the maximum
beam intensity for all ions.
The adapted DDS has also been updated, as described by Lis et al. [10]. Modifications have
been made from the original DDS design [27] to repackage the system as a fully modular design,
with integrated motion detection and motion-synchronized delivery capabilities. This upgrade,
including several significant changes and upgrades to the hardware and software of the DDS, is an
example of how we envision the future use of Cave M: as a testing facility for pre-clinical research
on delivery strategies that require intervention with the accelerator line and would provide undue
risk if performed in clinical environment, but are posed to produce major advances in radiation
therapy if thoroughly investigated and vetted before being implemented to clinic practice.
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